IMGT Co.,Ltd. (XKON:456570)

Market Cap	105.07B +135.6%
Revenue (ttm)	102.33M +7,832.6%
Net Income	731.32M
EPS	812.00
Shares Out	5.26M
PE Ratio	24.62
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,809
Average Volume	3,733
Open	19,990
Previous Close	n/a
Day's Range	19,630 - 20,000
52-Week Range	9,600 - 23,000
Beta	0.55
RSI	57.61
Earnings Date	n/a

About IMGT Co.,Ltd.

IMGT Co.,Ltd. engages in researching and developing of an ultrasound-guided therapy technology for genetic therapy and drug delivery systems. It develops IMGT-LPS, a technology that injects ultrasound-sensitive nanoparticles in the form of liposome-wrapped pharmacological substances into the body and releases drugs by irradiating ultrasound to the target area(tumor); IMGT-EMB, a nanoparticle for chemoembolization of liver cancer; IMGT-TSD, a targeted sonodynamic therapy that induces immune boosting mechanism by applying ultrasonic stimulation t...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2010
• Country: South Korea
• Stock Exchange: Korea New Exchange
• Ticker Symbol: 456570